Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
52 studies found for:    " June 01, 2011":" July 01, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence
Conditions: Acute HIV Infection;   Acquired Immunodeficiency Syndrome;   Medication Adherence
Intervention: Behavioral: Advanced Adherence Counseling (AdvAdh)
22 Completed Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics
Condition: HIV
Intervention: Drug: zidovudine 300mg and lamivudine 150mg as Combivir
23 Completed Maraviroc Switch Collaborative Study
Condition: HIV
Intervention: Drug: Maraviroc
24 Completed HIV Screening Take-up: Evaluating Incentives and Opt-out Strategies
Condition: HIV
Interventions: Behavioral: Monetary Incentive;   Behavioral: Questionnaire Timing;   Behavioral: HIV Test Offering
25 Active, not recruiting A Randomized Controlled Trial of HIV Testing and Linkage to Care at Community Corrections
Condition: HIV
Intervention: Behavioral: Project Bridge
26 Completed
Has Results
A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients
Condition: Human Immunodeficiency Virus 1
Interventions: Drug: Darunavir(DRV);   Drug: Ritonavir;   Drug: 2 nucleoside reverse transcriptase inhibitors (NRTIs)
27 Unknown  Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults
Conditions: HIV Seronegativity;   HIV Preventive Vaccine
Interventions: Biological: MVA-C + gp140/MF59;   Biological: DNA-C2 + MVA-C;   Biological: DNA-C2 + MVA-C + gp140/MF59
28 Active, not recruiting HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
Condition: Human Immunodeficiency Virus-1
Interventions: Drug: BMS-663068;   Drug: Raltegravir;   Drug: Tenofovir;   Drug: Ritonavir;   Drug: Atazanavir
29 Completed
Has Results
Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use
Condition: HIV-1 Patients
Intervention:
30 Completed The Role of Genital Warts in HIV Acquisition in Peru
Conditions: Anogenital Warts;   HIV
Intervention:
31 Completed
Has Results
Trial of Collaborative Depression Care Management for HIV Patients
Conditions: Depression;   HIV
Interventions: Other: Measurement-Based Care collaborative depression management;   Other: Enhanced Usual Care
32 Completed Treating South African Pregnant Women for Methamphetamine
Conditions: HIV;   Drug Addiction
Interventions: Behavioral: Psycho-education;   Behavioral: Experimental
33 Recruiting Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
Conditions: HIV;   Opiate Dependence
Interventions: Behavioral: Abstinence-reinforcing contingency management intervention;   Behavioral: Performance Feedback intervention
34 Completed Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults
Conditions: HIV;   Human Papillomavirus
Interventions: Biological: Gardasil;   Biological: Cervarix
35 Active, not recruiting Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder
Conditions: HIV;   Alcohol Use Disorder
Interventions: Drug: oral naltrexone;   Drug: Placebo pill
36 Completed Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa
Conditions: HIV;   Impaired Cognition
Interventions: Drug: standard care;   Drug: novel treatment
37 Unknown  Trial of Safe Water Storage Among People Living With HIV
Conditions: Diarrhea;   Waterborne Disease;   HIV
Intervention: Device: Safe storage device
38 Completed Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals
Conditions: Influenza, Human;   Human Immunodeficiency Virus I Infection
Intervention:
39 Active, not recruiting HIV, Buprenorphine, and the Criminal Justice System
Conditions: Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome;   Opiate Addiction;   Drug Dependence
Intervention: Drug: Buprenorphine/naloxone
40 Completed Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel
Condition: Prevention
Intervention: Drug: Tenofovir 1% vaginal gel

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-52) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.